Login / Signup

Acceptability of no-test medical abortion provided via telemedicine during Covid-19: analysis of patient-reported outcomes.

Chelsey Porter ErlankJonathan LordKathryn Church
Published in: BMJ sexual & reproductive health (2021)
Telemedicine EMA is a valued, private, convenient and more accessible option that is highly acceptable for patients seeking an abortion, especially those for whom in-clinic visits are logistically or emotionally challenging. Evidence that this pathway would be a first choice again in future for most patients supports the case to make telemedicine EMA permanent.
Keyphrases
  • patient reported outcomes
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • healthcare
  • peritoneal dialysis
  • prognostic factors
  • mental health
  • current status
  • patient reported